Monopar Therapeutics (MNPR) Assets Growth (1y) (2017 - 2025)
Monopar Therapeutics (MNPR) Assets Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 133.40% |
| Sep 30, 2025 | 2,275.71% |
| Jun 30, 2025 | 650.24% |
| Mar 31, 2025 | 518.08% |
| Dec 31, 2024 | 720.83% |
| Sep 30, 2024 | -29.37% |
| Jun 30, 2024 | -30.55% |
| Mar 31, 2024 | -24.68% |
| Dec 31, 2023 | -44.47% |
| Sep 30, 2023 | -40.51% |
| Jun 30, 2023 | -38.23% |
| Mar 31, 2023 | -34.51% |
| Dec 31, 2022 | -35.55% |
| Sep 30, 2022 | -35.85% |
| Jun 30, 2022 | -31.57% |
| Mar 31, 2022 | -30.26% |
| Dec 31, 2021 | 21.66% |
| Sep 30, 2021 | 24.02% |
| Jun 30, 2021 | 91.03% |
| Mar 31, 2021 | 101.78% |